GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Next Science Ltd (ASX:NXS) » Definitions » Price-to-Funds-From-Operations

Next Science (ASX:NXS) Price-to-Funds-From-Operations : (As of Apr. 02, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Next Science Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Next Science Business Description

Traded in Other Exchanges
Address
264-278 George Street, Level 14, Australia Square, HWL Ebsworth, Sydney, NSW, AUS, 2000
Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with efficacy in eradicating both biofilm-based and free-floating bacteria. Its products include Bactisure, SURGX, XEPERIENCE and BLASTX. The company derives revenue from North America, New Zealand, and Australia.